The Bio Report – Podcast: Boosting the Power of Dendritic Cancer Vaccines

Diakonos Oncology Announces First Patients Dosed in Phase 1/2 DOC-RM Study of DOC1021 in Refractory Melanoma

PR Biotech Nation with Moira Gunn

Cell & Gene with Erin Harris